TransMedics Group is trading 4.24% higher in pre-market at $73.62; no clear company-specific announcement or other confirmed catalyst for the October 27 move was identified.
- The company’s latest posted release says third-quarter 2026 results are scheduled for November 5, after market close; it does not explain the move.
- Trading volume and other activity data were not available in the provided context or results.